The Brain & Conduct Analysis Foundation is dedicated to alleviating the suffering due to mental health issues by awarding grants which will bring on advancements and breakthroughs in scientific investigation.Ketamine can be a Program III drug during the U.S.—i.e., a single with “a moderate to low potential for physical and psychological depende
MUSE Microscopy, Inc., a innovator in digital pathology announced it’s in their final phase. After a strategic acquisition by the current leadership team in 2021, MUSE has steadfastly pursued a visionary roadmap that has the potential to reshape the future of digital pathology. Today, that journey reaches an exciting moment with SmartPath MUSE Te
MUSE Microscopy, Inc., a innovator in digital pathology announced it’s in their final phase. After a strategic acquisition by the current leadership team in 2021, MUSE has steadfastly pursued a visionary roadmap that has the potential to reshape the future of digital pathology. Today, that journey reaches an exciting moment with SmartPath MUSE Te
MUSE Microscopy, Inc., a innovator in digital pathology announced it’s in their final phase. After a strategic acquisition by the current leadership team in 2021, MUSE has steadfastly pursued a visionary roadmap that has the potential to reshape the future of digital pathology. Today, that journey reaches an exciting moment with SmartPath MUSE Te
MUSE Microscopy, Inc., a innovator in digital pathology announced it’s in their final phase. After a strategic acquisition by the current leadership team in 2021, MUSE has steadfastly pursued a visionary roadmap that has the potential to reshape the future of digital pathology. Today, that journey reaches an exciting moment with SmartPath MUSE Te